Your session is about to expire
← Back to Search
Behavioral Intervention
EFT for Cancer-related Anxiety and Depression
Phase < 1
Waitlist Available
Led By Dawson Church, PhD
Research Sponsored by Soul Medicine Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of cholangiocarcinoma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial teaches cholangiocarcinoma patients a technique called EFT through online coaching to help reduce anxiety and depression. The study aims to see if this method can improve their mental health and quality of life. Participants' symptoms are measured at different stages of the coaching process. EFT (Emotional Freedom Techniques) has been studied as a treatment for anxiety, depression, and stress in various populations, including nursing students and individuals with chronic conditions.
Who is the study for?
This trial is for patients with cholangiocarcinoma, a rare bile duct cancer. Participants must be able to fill out forms and attend coaching sessions over the phone. There are no specific exclusion criteria listed, so it's open to individuals who meet the inclusion conditions.
What is being tested?
The study tests if Emotional Freedom Techniques (EFT), taught through phone and internet group sessions, can reduce anxiety and depression in cancer patients. It includes assessments before, during, and up to one year after EFT coaching using various psychological and quality of life scales.
What are the potential side effects?
Since EFT involves counseling without medication or invasive procedures, significant physical side effects are not expected. However, discussing emotional topics may sometimes lead to temporary increases in distress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with bile duct cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Lifestyle Counseling with Emotional Freedom Techniques (EFT)
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for depression, such as Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and mindfulness-based therapies, work by addressing negative thought patterns, emotional regulation, and stress reduction. These therapies help patients reframe negative thoughts, develop coping strategies, and improve emotional resilience.
EFT, similar to these therapies, combines cognitive and somatic elements by having patients tap on specific body points while focusing on emotional issues, aiming to reduce symptoms of anxiety, depression, pain, and insomnia. These treatments are crucial for depression patients as they provide tools to manage symptoms, improve quality of life, and reduce the risk of relapse.
Find a Location
Who is running the clinical trial?
Soul Medicine InstituteLead Sponsor
11 Previous Clinical Trials
636 Total Patients Enrolled
3 Trials studying Depression
190 Patients Enrolled for Depression
Dawson Church, PhDPrincipal Investigator - Soul Medicine Institute
Soul Medicine Institute
7 Previous Clinical Trials
390 Total Patients Enrolled
2 Trials studying Depression
120 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.I have been diagnosed with bile duct cancer.
Research Study Groups:
This trial has the following groups:- Group 1: 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger